Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo vs. KBP: How a $1.3B deal turned into an international legal fight
Research
Research
How Nobel-winning cells could become a ‘universal drug’
With their broad ability to tamp down immune activity, regulatory T cells could potentially be harnessed to treat just about any inflammatory disease.
Darren Incorvaia
Oct 21, 2025 2:00pm
Science's retinal implant restores some vision in AMD patients
Oct 21, 2025 6:50am
2 European biotechs link to tackle neurodegenerative diseases
Oct 20, 2025 8:20am
Sophia unveils 'digital twins' to personalize cancer treatment
Oct 18, 2025 4:45am
Kite puts $1.64B on the line for Pregene's in vivo CAR-Ts
Oct 16, 2025 4:56pm
'Let that one go': Nkarta CEO urges US gov to drop China regs
Oct 16, 2025 2:00pm